短期成功、长期失败:菌株更替与毒力再现可能驱动储袋炎复发
本研究前瞻性纳入21例IPAA术后储袋炎患者,在临床发作期接受2周甲硝唑联合环丙沙星或多西环素治疗并随访1年。两种方案均快速但短暂改善临床和粪钙卫蛋白(728降至265 μg/g,P<.05),细菌外毒素基因显著减少(P<.05),但6周后反弹;治疗期间抗生素耐药基因丰度显著增加(P<.05),多样性未扩大。
要点
- 抗生素诱导储袋炎缓解是短暂抑制产外毒素菌,耐药低毒力菌株暂时占优。
- 停药6周后粪钙卫蛋白与外毒素基因反弹,提示需靶向策略维持微生物控制。
- 治疗期间耐药基因丰度增加而多样性未扩大,提示预存耐药株扩增。
核心结论
- 抗生素诱导的储袋炎缓解可能源于产外毒素细菌的暂时抑制,使耐药低毒力菌株短暂占优,停药后有害菌株快速反弹。
研究设计与样本
- 前瞻性队列研究,纳入IPAA术后储袋炎临床发作期患者21例,接受2周甲硝唑联合环丙沙星或多西环素治疗,随访1年,收集130份粪便样本。
主要发现
- 两种抗生素方案均诱导快速但短暂的临床改善,粪钙卫蛋白从728降至265 μg/g(P<.05)。
- 治疗期间细菌外毒素基因显著减少(P<.05),但6周后粪钙卫蛋白和外毒素基因均反弹。
- 治疗期间抗生素耐药基因丰度显著增加(P<.05),耐药基因多样性未扩大,提示预存耐药株扩增。
关键数值与推荐
- 储袋炎活动期采用储袋炎疾病活动指数(Pouchitis Disease Activity Index)定义。
- 粪钙卫蛋白从728降至265 μg/g(P<.05),6周后反弹。
- 抗生素耐药基因丰度治疗期间显著增加(P<.05),多样性未扩大。
临床怎么用
- 抗生素治疗储袋炎可快速缓解但易复发,应预期6周内反弹并考虑靶向微生物维持策略。
- 治疗期间耐药基因丰度增加,提示需关注耐药风险并避免长期经验性抗生素。
局限性
- 样本量较小(n=21),随访1年,结果需更大队列验证。
- 原文未报告随机分组细节、具体耐药基因种类及外毒素基因名称。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Pouchitis, de novo small intestinal inflammation, is the most common complication developing in patients with ulcerative colitis after total large bowel resection and ileal pouch-anal anastomosis (IPAA) reconstruction. Although the first line treatment is antibiotics, the microbial properties underlying flare, remission, and relapse remain vague. We aimed to investigate how antibiotic treatment drives microbial shifts that underlie remission and contribute to relapse. METHODS: Patients after IPAA were prospectively recruited during clinical flare (active pouchitis defined using the Pouchitis Disease Activity Index) and received a 2-week course of metronidazole with either ciprofloxacin or doxycycline. Longitudinal follow-up was conducted during a year. Clinical data were recorded, and fecal samples were obtained during consequent flares, recovery, and relapses. Microbial gene repertoire, strains, and resistance to antibiotics were determined. Metagenomic sequencing was integrated with whole-genome sequencing of Escherichia coli isolates, providing strain-specific virulence and antibiotic resistance profiles. RESULTS: Patients (n = 21) recruited provided 130 samples over 1-year follow-up. Both antibiotic regimens induced rapid but transient clinical improvement, reflected by a decrease in fecal calprotectin (728 to 265 μg/g; P < .05), and a marked reduction in bacterial exotoxin genes (P < .05), yet both parameters rebounded by 6 weeks post-treatment. Antibiotic resistance gene abundance significantly increased during treatment (P < .05), without expansion of resistance gene diversity, indicating that pre-existing resistant strains increased. CONCLUSIONS: Antibiotic-induced remission in pouchitis likely results from a temporary suppression of exotoxin-producing bacteria, enabling resistant, low-virulence strains to transiently dominate. The fact that harmful strains quickly rebound after treatment cessation highlights the need for targeted approaches to achieve sustained microbial control.
引用
- Bilinsky L, Shamay T, Reshef L, et al. Short-Term Success, Long-Term Failure: Strain Turnover and Virulence Re-Emergence May Drive Relapse in Pouchitis. Gastroenterology. 2026. PMID: 42716140. doi:10.1053/j.gastro.2026.08.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。